Cyclopentolate HCL
Cyclopentolate HCL Brand names, Cyclopentolate HCL Analogs
Cyclopentolate HCL Brand Names Mixture
- No information avaliable
Cyclopentolate HCL Chemical_Formula
C17H25NO3
Cyclopentolate HCL RX_link
No information avaliable
Cyclopentolate HCL fda sheet
Cyclopentolate HCL msds (material safety sheet)
Cyclopentolate HCL Synthesis Reference
No information avaliable
Cyclopentolate HCL Molecular Weight
291.385 g/mol
Cyclopentolate HCL Melting Point
139 oC (hydrochloride salt)
Cyclopentolate HCL H2O Solubility
No information avaliable
Cyclopentolate HCL State
Solid
Cyclopentolate HCL LogP
3.124
Cyclopentolate HCL Dosage Forms
Ophthalmic solution (eye drops)
Cyclopentolate HCL Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Cyclopentolate HCL Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Cyclopentolate HCL Absorption
Absorbed following ophthalmic administration.
Cyclopentolate HCL side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
Cyclopentolate HCL Patient Information
No information avaliable
Cyclopentolate HCL Organisms Affected
Humans and other mammals
